Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study
Angela Huttner(University Hospital of Geneva), Sélidji Todagbé Agnandji(Albert Schweitzer Hospital), Christophe Combescure(University Hospital of Geneva), José F. Fernandes(Albert Schweitzer Hospital), Emmanuel B. Bache(Albert Schweitzer Hospital), Lumeka Kabwende(Albert Schweitzer Hospital), Francis M. Ndungu(Kenya Medical Research Institute), Jessica S. Brosnahan(Albert Schweitzer Hospital), Thomas P. Monath(NewLink Genetics (United States)), Barbara Lemaître(University Hospital of Geneva), Stéphane Grillet(University Hospital of Geneva), Miriam Botto(United States Army Medical Research Institute of Infectious Diseases), Olivier Engler(Spiez Laboratory), Jasmine Portmann(Spiez Laboratory), Denise Siegrist(Spiez Laboratory), Philip Bejon(Kenya Medical Research Institute), Peter Silvera(United States Army Medical Research Institute of Infectious Diseases), Peter G. Kremsner(Albert Schweitzer Hospital), Claire‐Anne Siegrist(University of Geneva), Sanjeev Krishna, Marylyn M. Addo, Stephan Becker(University Hospital of Geneva), Verena Krähling, Patricia Njuguna, Marie-Paule Kiény, Rafi Ahmed, Jenna Anderson, Floriane Auderset, Luisa Borgianni, Annalisa Ciabattini, Mariëlle C. Haks, Ali M. Harandi, Donald Gray Heppner, Alice Gerlini, Donata Medaglini, Tom H. M. Ottenhoff, David Pejoski, Mark Page, Gianni Pozzi, Francesco Santoro, Sheri Dubey, José F. Fernandes(Albert Schweitzer Hospital), Helder I. Nakaya, Fiona O’Rourke, Gianni Pozzi, Sylvia Rothenberger
Cited by 81Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis